Skip to main content
Log in

Fumonisins: current research trends in developmental toxicology

  • Published:
Mycotoxin Research Aims and scope Submit manuscript

Abstract

Fumonisin B1 (FB1) is a mycotoxin produced byFusarium verticillioides that is found in maize and maize-based foods. Reproductive studies in CD1 mice, rats and rabbits initially found no evidence that fumonisins are teratogenic. However, more recent findings suggest that they might increase the risk of neural tube defects (NTDs) in populations consuming large amounts of fumonisin-contaminated corn. When ≥15 mg/kg body weight fumonisin B1 (FB1) was given to pregnant LM/Bc mice by intraperitoneal (ip) injection, all litters were positive for NTDs. To determine if NTD induction is unique to the inbred LM/Bc mouse strain, NTD induction in LM/Bc and CD1 mice was compared: (a) in a study in whichF. verticillioides culture material providing ≤150 ppm FB1 was fed to female mice before and during gestation, and (b) in a study in which FB1 was given by ip injection to CD1 dams on gestation days 7 and 8, the critical time for NTD development. In the feeding study, one of five LM/Bc litters from dams fed the 150 ppm FB1 diet was positive for NTDs whereas no NTDs were found in the CD1 litters. In the ip injection study, 40% of the litters at the highest dose tested, 45 mg/kg body weight, were positive for NTDs and one of nine low-dose (15 mg/kg body weight) litters was also positive. Thus, FB1 induced NTDs in both LM/Bc and CD1 mice although the latter strain appears less sensitive. Comparative investigations using these strains will be useful for elucidating the mechanisms underlying fumonisin-induced NTDs in mice and determining the suitability of mouse models for studying the relationships between fumonisins and NTDs in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gelderblom WCA, Jaskiewicz K, Marasas WFO, Thiel PG, Horak RM, Vleggaar R, Kriek NP (1988) Fumonisins-novel mycotoxins with cancer promoting activity produced byFusarium moniliforme. Appl Environ Microbiol 54: 1806–1811

    PubMed  CAS  Google Scholar 

  2. Bolger M, Coker RD, DiNovi M, Gaylor D, Gelderblom WCA, Olsen M, Paster N, Riley RT, Shephard G, Speijers GJA (2001) Fumonisins. In: Safety Evaluation of Certain Mycotoxins in Foods. FAO Food and Nutrition Paper 74, World Health Organization. Geneva, 103–279

    Google Scholar 

  3. Humpf HU, Voss KA (2004) Effects of food processing on the chemical structure and toxicity of fumonisin mycotoxins. Mol Nutr Food Res 48: 255–269

    Article  PubMed  CAS  Google Scholar 

  4. Kritzinger Q, Aveling TAS, Marasas WFO, Rheeder JP, van der Westhuizen L, Shepard GS (2003) Mycoflora and fumonisin mycotoxins associated with cowpea (Vigna unguiculata (L.) Walp) seeds. J Agric Food Chem 51: 2188–2192

    Article  PubMed  CAS  Google Scholar 

  5. Seefelder W, Gossmann M, Humpf HU (2002) Analysis of fumonisin B1 inFusarium proliferatum-infected asparagus spears and garlic bulbs from Germany by liquid chromatographyelectrospray ionization mass spectrometry. J Agric Food Chem 50: 2778–2881

    Article  PubMed  CAS  Google Scholar 

  6. da Silva JB, Pozzi CR, Mallozzi MA, Ortega EM, Correa B (2000) Mycoflora and occurrence of aflatoxin B1 and fumonisin B1 during storage of Brazilian sorghum. J Agric Food Chem 48: 4352–4356

    Article  PubMed  CAS  Google Scholar 

  7. Abbas HK, Cartwright RD, Xie W, Mirocha CJ, Richard JL, Dvorak TJ, Sciumbato GI, Shier WT (1999) Mycotoxin production byFusarium proliferatum isolates from rice withFusarium sheath rot disease. Mycopathologia 147: 97–104

    Article  PubMed  CAS  Google Scholar 

  8. Castoria R, Lima G, Ferracane R, Ritieni A (2005) Occurrence of mycotoxin in Farro samples from southern Italy. J Food Prot 68: 416–420

    PubMed  CAS  Google Scholar 

  9. Voss KA, Riley RT, Norred WP, Bacon CW, Meredith FI, Howard PC, Plattner RD, Collins TFX, Hansen DK, Porter JK (2001) An overview of rodent toxicities: liver and kidney effects of fumonisins andFusarium moniliforme. Environ Health Persp 109 (Suppl. 2): 259–266

    Article  CAS  Google Scholar 

  10. Howard PC, Eppley RM, Stack ME, Warbritton A, Voss KA, Lorentzen RJ, Kovach RM, Bucci TJ (2001) Fumonisin B1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ Health Persp 109 (Suppl. 2): 277–282

    Article  CAS  Google Scholar 

  11. Gelderblom WCA, Kriek NPJ, Marasas WFO, Thiel, PG (1991) Toxicity and carcinogenicity of theFusarium moniliforme metabolite fumonisin B1 in rats. Carcinogenesis 12: 1247–1251

    Article  PubMed  CAS  Google Scholar 

  12. Doko MB, Visconti A (1994) Occurrence of fumonisin B1 and B2 in corn and corn-based human foodstuffs in Italy. Food Addit Contam 11: 433–439

    PubMed  CAS  Google Scholar 

  13. Franceschi S, Bidoli E, Barón AE, La Vacchia C (1995) Maize and risk of cancer of the oral cavity, pharynx, and esophagus in northern Italy. J Natl Cancer Inst 82: 1407–1411

    Article  Google Scholar 

  14. Shephard GS, Marasas WF, Yazdanpanah H, Rahimian H, Safavi N, Zarghi A, Shafaati A, Rasekh HR (2002) Fumonisin B1 in maize harvested in Iran during 1999. Food Addit Contam 19: 676–679

    Article  PubMed  CAS  Google Scholar 

  15. International Agency for Research on Cancer (2002) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC Press, Lyon, 301–366

    Google Scholar 

  16. Hendricks K (1999) Fumonisins and neural tube defects in South Texas. Epidemiol 10: 198–200

    CAS  Google Scholar 

  17. Gelineau-van Waes JB, Starr L, Maddox JR, Aleman F, Voss KA, Wilberding J, Riley RT (2005) Maternal fumonisin exposure and risk for neural tube defects: mechanisms in anin vivo mouse model. Birth Defects Res Part A Clin Mol Teratol 73: 487–497

    Article  PubMed  CAS  Google Scholar 

  18. Marasas WFO, Riley RT, Hendricks KA, Stevens VL, Sadler TW, Gelineau-van Waes J, Missmer SA, Cabrera J, Torres O, Gelderblom WCA, Miller JD, Starr L, Sullards MC, Roman AV, Voss KA, Wang E, Merrill AH Jr. (2004) Fumonisins disrupt sphingolipid metabolism, folate transport and development of neural crest cells in embryo culture andin vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr 134: 711–716

    PubMed  CAS  Google Scholar 

  19. Merrill AH Jr, Sullards MC, Wang E, Voss KA, Riley RT (2001) Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins, Environ Health Persp 109 (Suppl. 2): 283–289

    Article  CAS  Google Scholar 

  20. Riley RT, Enongene EN, Voss KA, Norred WP, Meredith FI, Sharma RP, Spitsbergen J, Williams DE, Carlson DB, Merrill AH Jr (2001) Sphingolipid perturbations as mechanisms for fumonisin careinogenesis. Environ Health Persp 109 (Suppl. 2): 301–308

    Article  CAS  Google Scholar 

  21. Pyne S, Pyne NJ (2000) Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 15: 385–402

    Article  Google Scholar 

  22. Pelagalli A, Belisario MA, Squillacioti C, Morte RD, d'Angelo D, Tafuri S, Lucisano A, Staiano N (1999) The mycotoxin fumonisin B1 inhibits integrin-mediated cell-matriz adhesion. Biochemie 81: 1003–1008

    Article  CAS  Google Scholar 

  23. Ramasamy S, Wang E, Henning B, Merrill AH Jr (1995) Fumonisin B1 alters sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture. Toxicol Appl Pharmacol 133: 343–248

    Article  PubMed  CAS  Google Scholar 

  24. Gon Y, Wood MR, Kiosses WB, Jo E, Germanna Sanna M, Chun J, Rosen H (2005) SIP3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. PNAS 102L 9270–9275

    Article  CAS  Google Scholar 

  25. Sharma RP, He Q, Johnson VJ, Voss KA (2003) Increased expression of CD95-ligand and other apoptotic signaling factors by fumonisin B1, a hepatotoxic mycotoxin, in livers of mice lacking tumor necrosis factoralpha. Cytokine 24: 226–236

    Article  PubMed  CAS  Google Scholar 

  26. Gelderblom WCA, Abel S, Smuts C, Marnewick J, Marasas WFO, Lemmer ER, Ramljak D (2001) Fumonisin-induced carcinogenesis: mechanisms related to cancer initiation and promotion. Environ Health Persp 109 (Suppl. 2): 291–300

    Article  CAS  Google Scholar 

  27. Sadler TW, Merrill AH Jr, Stevens VL, Sullards MC, Wang E, Wang P (2002) Prevention of fumonisin B1-induced neural tube defects by folic acid. Teratol 66: 169–176

    Article  CAS  Google Scholar 

  28. Flynn, TJ, Stack, ME, Troy, AL, Chirtel, SJ (1997) Assessment of the embryotoxic potential of the total hydrolysis product of fumonisin B1 using organogenesis-staged rat embryos. Food Chem Toxicol 35: 1135–1141

    Article  PubMed  CAS  Google Scholar 

  29. Cabrera RM, Hill DS, Etheredge AJ, Fennell RH (2004) Investigations into the etiology of neural tube defects. Birth Defects Res C Embryo Today. 72: 330–44

    Article  PubMed  CAS  Google Scholar 

  30. Greene NDE, Copp AJ (2005) Mouse models of neural tube defects: investigating preventive mechanisms. Am J Med Gen Part C (Semin. Med. Genet.) 135C: 31–41

    Article  Google Scholar 

  31. Stevens VL, Tang J (1997) Fumonisin B1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol anchored folate receptor. J Biol Chem 272: 18020–18025

    Article  PubMed  CAS  Google Scholar 

  32. Voss KA, Bacon CW, Norred WP, Chapin RE, Chamberlain WJ, Plattner RD, Meredith FI (1996) Studies on the reproductive effects ofFusarium moniliforme culture material in rats and the biodistribution of [14C] fumonisin B1 in pregnant rats. Nat Toxins 4: 24–33

    Article  PubMed  CAS  Google Scholar 

  33. Lebepe-Mazur S, Bal H, Hopmans E, Murphy P, Hendrich S (1995) Fumonisin B1 is fetotoxic in rats. Vet Hum Toxicol 37: 126–130

    PubMed  CAS  Google Scholar 

  34. Collins TF, Shackelford ME, Sprando RI, Black TN, Laborde JB, Hansen DK, Eppley RM, Trucksess MW, Howard PC, Bryant MA, Ruggles DI, Olejnik N, Rorie JI (1998) Effects of fumonisin B1 in pregnant rats. Food Chem Toxicol 36: 397–408

    Article  PubMed  CAS  Google Scholar 

  35. Collins TF, Sprando RL, Black TN, Shackelford ME, Laborde JB, Hansen DK, Eppley RM, Trucksess MW, Howard PC, Bryant MA, Ruggles DI, Olejnik N, Rorie JI (1998) Effects of fumonisin B1 in pregnant rats. Food Chem Toxicol 36: 673–685

    Article  PubMed  CAS  Google Scholar 

  36. Reddy RV, Johnson G, Rottinghaus GE, Casteel SW, Reddy CS (1996) Developmental effects of fumonisin B1 in mice. Mycopathologia 134: 161–166

    Article  PubMed  CAS  Google Scholar 

  37. Floss JL, Casteel SW, Johnson GC, Rottinghaus GE, Krause GF (1994) Developmental toxicity of fumonisin in Syrian hamsters. Mycopathologia 128: 33–38

    Article  PubMed  CAS  Google Scholar 

  38. LaBorde JB, Terry KK, Howard PC, Chen JJ, Collins TF, Shackelford ME, Hansen DK (1997) Lack of embryotoxicity of fumonisin B1 in New Zealand white rabbits. Fundam Appl Toxicol 40: 120–128

    Article  PubMed  CAS  Google Scholar 

  39. Riley RT, Showker JL, Voss KA (2005) Time-and dose-dependent changes in sphingoid base 1-phosphates in tissues from rats fed diets containing fumonisins. Toxicol Sci (Suppl. The Toxicologist) 84 (S1): 284

    Google Scholar 

  40. Suarez L, Felkner M, Hendricks K (2004) The effect of fever, febrile illnesses, and heat exposures on the risk of neural tube defects in a Texas-Mexico border population. Birth Defects Res A Clin Mol Teratol 70: 815–819

    Article  PubMed  CAS  Google Scholar 

  41. Felkner M, Hendricks K, Suarez L, Waller DK (2003) Diarrhea: a new risk factor for neural tube defects? Birth Defects Res A Clin Mol Teratol 67: 504–508

    Article  PubMed  CAS  Google Scholar 

  42. Suarez L, Cardarelli K, Hendricks K (2003) Maternal stress, social support, and risk of neural tube defects among. Mexican Americans. Epidemiol 14: 612–616

    Google Scholar 

  43. Center for Food Safety and Nutritions, US Food and Drug Administration (2001) Final Guidance for Industry, Fumonisins in Foods and Animal Feeds. (November 9, 2001). http://www.cfsan. fda.gov/∼dms/fumongu2.html

  44. Center for Food Safety and Nutrition, US Food and Drug Administration (2001) Background Paper in Support of Fumonisin Levels in Animal Feed: Executive Summary of this Scientific Document (November 9, 2001) http://www.cfsan.fda.gov/∼dms/fumonbg4.html

  45. Commission of European Communities (2005) Commission Regulation (EC) No. 856/2005 of 6 June 2005 amending Regulation (EC) No 466/2001 as regardsFusarium toxins. Off J Eur Union 48: 3–8

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. A. Voss.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Voss, K.A., Gelineau-van Waes, J.B. & Riley, R.T. Fumonisins: current research trends in developmental toxicology. Mycotox Res 22, 61–69 (2006). https://doi.org/10.1007/BF02954559

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02954559

Keywords

Navigation